Oral microbiome and dental surfaces

The oral microbiome and dental surfaces represent a complex ecological niche consisting of a diverse community of bacteria, fungi, and viruses living in a biofilm state on the hard and soft tissues of the mouth (NIH, 2023). This environment is central to oral health, as the balance between commensal and pathogenic microorganisms determines the risk for common conditions like dental caries and periodontal disease (WHO, 2023). Dental surfaces, primarily composed of hydroxyapatite, serve as the substrate for biofilm attachment and are subject to constant cycles of demineralization and remineralization (StatPearls, 2023). Therapeutic strategies often focus on non-specific control of the biofilm through mechanical removal or chemical antimicrobial agents, as well as the chemical modification of the tooth surface to enhance acid resistance (PubChem). Because this target encompasses an entire ecosystem rather than a single molecular entity, pharmacological interventions are generally broad-spectrum and aimed at maintaining homeostatic balance rather than inhibiting a specific protein.

Other names

Dental plaqueOral biofilmDental enamelOral microfloraDental pellicle

Drugs targeting this environment act through various non-specific mechanisms, including the disruption of microbial cell membranes (e.g., chlorhexidine), inhibition of bacterial enzymes involved in glycolysis, and the promotion of enamel remineralization through the formation of fluorapatite (e.g., fluoride) (PubChem; StatPearls, 2023). Antimicrobial agents like chlorhexidine provide long-lasting bacteriostatic effects by binding to oral surfaces, while fluoride ions integrate into the dental hydroxyapatite lattice to increase resistance to acid-induced demineralization (PubMed, PMID: 28910391).